Sensei Biotherapeutics reports annual meeting results; all director nominees elected, Deloitte ratified

Sensei Biotherapeutics, Inc.

Bob Holmen elected with 12,245,867 votes for, 2,181,612 withheld.
Kristian Humer elected with 11,914,421 votes for, 2,513,058 withheld.
Deneen Vojta elected with 11,503,426 votes for, 2,924,053 withheld.
Broker non-votes of 2,117,571 on each director proposal.
Ratification of Deloitte & Touche as auditor passed with 16,096,264 for, 571 against, 448,215 abstained.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sensei Biotherapeutics, Inc. shareholders approved Election of three nominees to serve as directors on the Board of Directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified at the 2023-07-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-07-10

Exact text from the filing

Proposal No. 1 : Election of three nominees to serve as directors on the Board of Directors until the 2026 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: Name Votes For Votes Withheld Broker Non-Votes Bob Holmen 12,245,867 2,181,612 2,117,571 Kristian Humer 11,914,421 2,513,058 2,117,571 Deneen Vojta 11,503,426 2,924,053 2,117,571 All nominees were elected.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sensei Biotherapeutics, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-07-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-07-10

Exact text from the filing

Proposal No. 2 : Ratification of the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The votes were cast as follows: Votes For Votes Against Abstained 16,096,264 571 448,215

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sensei Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-184650

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.